Nitazoxanide for the Treatment of Clostridium difficile Colitis
Top Cited Papers
Open Access
- 15 August 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (4) , 421-427
- https://doi.org/10.1086/506351
Abstract
Background. Clostridium difficile colitis has increased in incidence and severity, and treatment failure with metronidazole therapy has increasinglyKeywords
This publication has 25 references indexed in Scilit:
- EpidemicClostridium difficileNew England Journal of Medicine, 2006
- A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and MortalityNew England Journal of Medicine, 2005
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileNew England Journal of Medicine, 2005
- Treatment of Clostridium difficile-associated disease: old therapies and new strategiesThe Lancet Infectious Diseases, 2005
- Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and EuropeThe Lancet, 2005
- Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with MetronidazoleClinical Infectious Diseases, 2005
- A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone UseInfection Control & Hospital Epidemiology, 2005
- A Hospital Outbreak of Clostridium difficile Disease Associated with Isolates Carrying Binary Toxin GenesClinical Infectious Diseases, 2005
- Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severityCMAJ : Canadian Medical Association Journal, 2004
- Secular Trends in Hospital‐AcquiredClostridium difficileDisease in the United States, 1987–2001The Journal of Infectious Diseases, 2004